Title for MeetingAbstracts
Alphabetical listing of titles
-
Pharmacokinetics (PK) of Concomitantly Administered Gatifloxacin and Digoxin.
-
Pharmacokinetics (pK) of didanosine (ddI) from encapsulated enteric coated bead formulation (EC) vs chewable tablet formulation in patients (pts) on chronic methadone therapy.
-
Pharmacokinetics (PK) of hyperimmune HIV immunoglobulin (HIVIG) in HIV+ pregnant females & newborns.
-
Pharmacokinetics (PK) of lamivudine (3TC TM) in HIV infected patients with renal dysfunction.
-
Pharmacokinetics (PK) of Lower Doses of Saquinavir Soft Gel Caps (SQV) (800- and 1200-mg BID) with Itraconazole (Itra) Compared to 1400 mg SQV BID without Itra in HIV-1+ Thai Patients.
-
Pharmacokinetics (PK) of nelfinavir (NFV) after once daily dosing in combination with mini-doses of ritonavir (RTV) in healthy subjects.
-
Pharmacokinetics (PK) of Nelfinavir (NFV) and Metabolite M8 in Patients with Liver Impairment after a Single Oral 750mg Dose of Viracept.
-
Pharmacokinetics (PK) of Nelfinavir (NFV) in African American and Caucasian HIV Patients.
-
Pharmacokinetics (PK) of nelfinavir and its metabolite (M8) in HIV-infected infants following bid or tid administration.
-
Pharmacokinetics (PK) of Nelfinavir in HIV Infected Infants.
-
Pharmacokinetics (PK) of Once Daily (QD) Saquinavir/ritonavir (SQV/RTV): Effects on Unbound Methadone and Alpha1-Acid Glycoprotein (AAG).
-
Pharmacokinetics (PK) of saquinavir (SQV) and nelfinavir (NFV) in a twice-daily (BID) regimen in HIV-infected children.
-
PHARMACOKINETICS (PK) OF SAQUINAVIR-HARD GEL CAPSULES (SQV-hgc) WHEN COMBINED WITH ATAZANAVIR (ATV) AS ONCE A DAY COMBINATION (1200/400) IN HIGHLY EXPERIENCED HIV-POSITIVE PATIENTS.
-
Pharmacokinetics (PK) of Saquinavir/Ritonavir (SQV/RTV) in HIV-Infected Pregnant Women.
-
Pharmacokinetics (PK) of selected doses of T-20, a fusion inhibitor, in HIV-1-infected children.
-
PHARMACOKINETICS (PK) OF SPD754, A NEW CYTIDINE ANALOGUE IN HEALTHY VOLUNTEERS.
-
Pharmacokinetics (PK) of Stavudine (d4T) Extended Release Formulation Compared with Stavudine Immediate Release (IR) Formulation as Part of Potent Antiretroviral Combination Therapy.
-
Pharmacokinetics (Pk) of the Combination of Ritonavir (RTV) Plus Saquinavir (SQV), with and without Efavirenz (EFV), in Healthy Volunteers.
-
Pharmacokinetics (PK) of Two Adjusted Dose Regimens of Lopinavir/Ritonavir (LPV/r) in Combination with Rifampin (RIF) in Healthy Volunteers.
-
Pharmacokinetics (PK) of zidovudine (ZDV) in adult patients with HIV infection and hepatic disease (HD).
-
Pharmacokinetics (Pk) of zidovudine (ZDV) in HIV+ pregnant women.
-
Pharmacokinetics (PK), Safety and Tolerability of E1010, a New Parenteral Long Half-life Carbapenem, in Healthy Male Volunteers.
-
Pharmacokinetics (PK), Safety and Tolerability of GAR-936, a Novel Glycylcycline Antibiotic, in Healthy Subjects.
-
Pharmacokinetics (PK), Safety, and Tolerability of SPK-843ID in Healthy Japanese Males.
-
Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline (GAR-936) in Healthy Japanese Males.
-
Pharmacokinetics (PK), safety, tolerability and efficacy of saquinavir hard-gel capsules/ritonavir (SQV/r) plus 2 nucleosides in HIV-1-infected pregnant women.
-
PHARMACOKINETICS (PKS) OF RIFABUTIN (RIF) COADMINISTERED WITH LOPINAVIR/RITONAVIR (LPV/r) IN HIV PATIENTS AFFECTED BY TUBERCULOSIS (TB).
-
Pharmacokinetics and bioavailability of fluconazole in patients with AIDS.
-
Pharmacokinetics and Diffusion Into Lung Tissue of Levofloxacin Administered to Critically Ill Patients with Severe Community-Acquired Pneumonia: a Comparison of Two Dosages.
-
Pharmacokinetics and Distribution of Nebulized Amphotericin B (n-Amp) in Lung Transplantation.